Streetbeat News

Stock Prices

BMY

A significant bearish stance has been taken on Bristol-Myers Squibb (BMY) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split, with 40% bullish and 60% bearish. The targeted price range for BMY over the last 3 months is from $62.5 to $70.0. The company's stock price is currently down by 1.3% at $63.89. Several financial institutions have recently updated their ratings and price targets for BMY.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:31 pm

CSCO

A significant amount of unusual options activity has been observed for Cisco Systems (NASDAQ:CSCO), with a bearish stance being taken by a majority of investors. The price target range for Cisco Systems over the last 3 months has been between $40.0 to $60.0. The company's stock price is currently up 0.84% at $53.55. Analysts have mixed opinions, with downgrades from Exane BNP Paribas and Citigroup, and an upgrade from JP Morgan.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:31 pm

EDTK

EEIQ

IRBT

LTH

MCFT

TUP

UHG

VRM

YOSH

During Tuesday's intraday session, several consumer discretionary stocks experienced significant movement. Yoshiharu Global (YOSH), Skillful Craftsman (EDTK), WW International (WW), Vroom (VRM), and MasterCraft Boat Hldgs (MCFT) saw gains, while Life Time Group Hldgs (LTH), iRobot (IRBT), Tupperware Brands (TUP), United Homes Gr (UHG), and EpicQuest Education Group (EEIQ) experienced losses. Trading volumes for these stocks were significantly higher than their average full-day volumes over the last 100 days.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:31 pm

AKBA

ARMP

BFRG

BLPH

GLTO

GNLX

HGEN

KNSA

NMTC

NMTR

STOK

TARS

During Tuesday's intraday session, several healthcare stocks experienced significant movements. Bullfrog AI Hldgs, Kiniksa Pharmaceuticals, Galecto, Armata Pharmaceuticals, Genelux, and Akebia Therapeutics saw their shares rise by 33.8%, 32.66%, 28.51%, 23.56%, 20.12%, and 18.44% respectively. On the other hand, Humanigen, Bellerophon Therapeutics, NeuroOne Medical Tech, Stoke Therapeutics, 9 Meters Biopharma, and Tarsus Pharmaceuticals saw their shares fall by 77.1%, 39.27%, 33.65%, 33.53%, 32.86%, and 24.74% respectively.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:31 pm

MKFG

TBI

During Tuesday's intraday session, several industrials stocks experienced significant movements. Markforged Holding (MKFG), Shengfeng Development (SFWL), Sunworks (SUNW), Lichen China (LICN), EHang Holdings (EH), and Momentus (MNTS) saw their stocks rise, with increases ranging from 9.11% to 20.5%. On the other hand, TrueBlue (TBI), RTX (RTX), Erayak Power Solution Gr (RAYA), Alaska Air Gr (ALK), Nikola (NKLA), and VCI Global (VCIG) saw their stocks fall, with decreases ranging from 8.42% to 18.1%.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:31 pm

INPX

ONDS

RGTI

RMNI

During Tuesday's intraday session, several information technology stocks experienced significant movements. Gainers included Inpixon (INPX), Rigetti Computing (RGTI), Pagaya Techs (PGY), Applied Digital (APLD), IDEX Biometrics (IDBA), and AEye (LIDR). Losers included Rimini Street (RMNI), Ondas Holdings (ONDS), SoundHound AI (SOUN), Cemtrex (CETXP), VIA optronics (VIAO), and ICZOOM Group (IZM).

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:30 pm

EADSY

Airbus SE is reportedly considering a management reshuffle that would separate the leadership of its plane-making business, freeing up CEO Guillaume Faury to focus on broader strategic initiatives. The timing and specifics of the new position are still unclear and depend on board approval. Airbus declined to comment on the speculation.

Portfolio Pulse from Nabaparna Bhattacharya

July 25, 2023 | 5:30 pm

AMAT

Applied Mat (NASDAQ:AMAT) has outperformed the market over the past 20 years, producing an average annual return of 10.37%. If an investor had bought $100 of AMAT stock 20 years ago, it would be worth $722.66 today.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:30 pm

STZ

Constellation Brands (NYSE:STZ) has outperformed the market over the past 20 years by 7.93% on an annualized basis, producing an average annual return of 15.9%. If an investor had bought $1000 of STZ stock 20 years ago, it would be worth $18,754.94 today.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:30 pm

DAL

Shares of Delta Air Lines, Inc. (NYSE:DAL) are trading lower by 2.19% to $46.44, in sympathy with Alaska Air, which fell after reporting Q2 earnings and guiding 0-3% topline growth in Q3. Alaska Air reported a 7% YoY increase in operating revenue, surpassing consensus estimates, and an adjusted EPS of $3.00, outperforming the previous year's $2.19.

Portfolio Pulse from Henry Khederian

July 25, 2023 | 5:29 pm